Harmon Cyrus sold OLMA
September 16, 2025 · Form 4 insider transaction
Harmon Cyrus sold 1,914 shares of Olema Pharmaceuticals, Inc. at $8.08 per share, a transaction worth $15.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,914
Price
$8.08
Total value
$15.5K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2025
Filing dateSeptember 18, 2025
Shares owned after120,114
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $8.08, and the range of prices was between $8.04 and $8.08. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.; The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.